What indicators would you like to setup a trade for?

Candlestick Daily volume index Bar reversal Edit

Trade setup

Position Order Entry Exit Stop Loss Risk Return Expectancy
Long 10 4.5 20% 25% 1.6% -0.8% -3.4%
Short 5 4.2 40% 67% 1.9% -3.2% -5.9%

What indicators would you like to backtest?

Candlestick Daily volume index Bar reversal Edit

Backtest results

Position Trades Duration Win rate Win/loss Avg win Avg loss Return
Long 10 4.5 20% 25% 1.6% -0.8% -3.4%
Short 5 4.2 40% 67% 1.9% -3.2% -5.9%



Code Company Date Close Change Indicator Value Signal

Trading Performance

Donchian Channels



Position Trades Duration Win Rate Win/Loss Avg Win Avg Loss Return
LONG 30 12.3 0.17% 0.20% 73.1% -3.9% 267.9%
SHORT 30 13.8 0.27% 0.32% 4.3% -4.0% -65.7%


Technical Analysis

Opthea (OPT.AX)



Last Signal:


Trading: SELL @ $2.67
Signal Strength: STRONG

Indicator is best used in conjunction with additional indicators as it has the ability to highlight potential overbought or oversold levels. This indicator utilizes upper and lower bands to visually represent price extremes associated with the bands. Additional value can be added to the trading strategy by accessing divergences between price and volume.

Opthea (ASX:OPT) is currently bearish highlighting the potential for a short term trend continuation in the downward direction.

The Donchian channel is a useful indicator for seeing the volatility of a market price. If a price is stable the Donchian channel will be relatively narrow. If the price fluctuates a lot the Donchian channel will be wider. The two outer bands are plotted as the highest high and lowest low for a set period originally 20 days with the optional middle band calculated as the average of the two.

Calculation: Donchian Channels:
1) Upper Channel = 20 Day High;
2) Lower Channel = 20 Day Low;
3) Middle Channel = (20 Day High + 20 Day Low)/2;


Stock Exchange: ASX
Company: Opthea
Ticker Codes: | OPT.AX | ASX:OPT |

About Opthea (ASX:OPT):

Opthea Limited develops and commercializes therapies primarily for eye disease in Australia. The company's development activities are based on the intellectual property portfolio covering Vascular Endothelial Growth Factors (VEGF) C and D, and VEGF Receptor-3 for the treatment of diseases associated with blood and lymphatic vessel growth, as well as vascular leakage. Its lead molecule is OPT-302, a soluble form of VEGFR-3, which is in Phase 1/2A clinical trial for the treatment of back of the eye diseases, such as wet age-related macular degeneration that is the cause of blindness in elderly and diabetic populations. The company was formerly known as Circadian Technologies Limited and changed its name to Opthea Limited in December 2015. Opthea Limited is based in South Yarra, Australia.

Top 10:

Donchian Channels

Company Close Change(%) Volume Value Signal
LYC Lynas Corporation 2.58 8.9 9,724,310 39.92 BULLISH
ISD Isentia 0.26 8.3 518,734 32.14 BULLISH
IMF IMF 3.81 6.7 2,751,384 6.41 BULLISH
BSL Bluescope Steel 15.21 5.2 2,787,185 5.98 BULLISH
RWC Reliance Worldwide Corporation 4.18 4.8 2,029,284 34.62 BULLISH
BFG Bell Financial 1.15 4.5 338,716 26.47 BULLISH
BSE BSE 0.23 4.5 2,037,922 33.33 BULLISH
MND Monadelphous 17.47 4.5 518,378 45.82 BULLISH
BSA Broadcast Services Australia 0.4 3.9 307,029 22.73 BULLISH
SFR Sandfire Resources 6.07 3.9 1,581,145 32.8 BULLISH